Cardiac magnetic resonance imaging may help clinicians predict future cardiac events among patients with coronary artery disease or recent MI.
Some MR imaging findings, such as left ventricular ejection fraction (LVEF), may have prognostic value regarding future cardiac events, according to a study published in the Journal of the American College of Cardiology.
Researchers from the Netherlands undertook a meta-analysis to review the prognostic value of cardiac magnetic resonance (CMR) in for future cardiovascular events in patients with coronary artery disease (CAD) or a recent myocardial infarction (MI).
The researchers identified 56 studies with 25,497 patients. After review, the researchers found that too few patients with a recent MI had been evaluated to establish associations between CMR findings and hard events (all-cause mortality, cardiac death, cardiac transplantation, and MI). However, it was found that in this group, LVEF was independently associated with major adverse cardiac events (MACE).
For patients with suspected or known CAD, the studies showed that wall motion abnormalities, inducible perfusion defects, LVEF, and infarction were independently associated with hard events. As well, the presence of inducible perfusion defects was associated with MACE.
The authors concluded that these findings indicate the utility of developing reporting guidelines using CMR among patients with CAD or recent MI.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.